ACHL logo

Achilles Therapeutics plc American Depositary Shares


ACHL: Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.


Show ACHL Financials

Consumer Interest
SEC Filings

Recent trades of ACHL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by ACHL's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Identification of clonal neoantigens and uses thereof Nov. 22, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ACHL in WallStreetBets Daily Discussion


Recent insights relating to ACHL

CNBC Recommendations

Recent picks made for ACHL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ACHL

Corporate Flights

Flights by private jets registered to ACHL